Summary
- Current Price
- As of today, TGTX price is $53.97, down -3.62% on
- Current Price All-Time High
- TGTX price is currently -76.88% below its historical high of $233.44 set on
- Market Cap
- TGTX current market cap is $8B, up +52.64% over the past 365 days
- PE Ratio
- TGTX current PE ratio is 19.66
- Revenue
- TGTX current annual revenue is $616.29M, up +87.32% year-over-year
- Next Earnings
- The next earnings release for TGTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | TG Therapeutics, Inc. |
| Ticker | NASDAQ: TGTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tgtherapeutics.com |
| Employees | 399 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $53.97 | |
| Price, 1D Change | -3.62% | |
| $8B | ||
| - | ||
| 19.66 | ||
| 0.51 | ||
| $616.29M | ||
| Revenue, 1Y Change | +87.32% | |
| $2.77 | ||
| EPS, 1Y Change | +1,800.14% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 4:225 | |
| Next Split | N/A | N/A |
| Last Ticker Change | MHAN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $2.77 | ||
| EPS Estimate | $0.95 | N/A |
| EPS Est. Change | -65.71% | N/A |
| $616.29M | ||
| Revenue Estimate | $960.26M | N/A |
| Revenue Est. Change | +55.81% | N/A |
| Current Price | $53.97 | |
| Price Target | $75.00 | - |
| Price Tgt. Change | +38.97% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.16 | $0.15 | -9.72% | |
| $2.97 | $2.77 | -6.69% | |
| $0.95 | N/A | -65.71% | |
| $2.71 | N/A | -2.25% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $321.55M | $329.00M | +2.32% | |
| $617.13M | $616.29M | -0.14% | |
| $960.26M | N/A | +55.81% | |
| $1.32B | N/A | +114.03% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $53.97 | |
| $42.49 | ||
| $54.14 | ||
| $45.81 | ||
| $54.06 | ||
| -$0.09 | ||
| 0.51 | ||
| $2.17 | ||
| 47.11 | ||
| 38.48% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $616.29M | ||
| $2.77 | ||
| $515.57M | ||
| 83.66% | ||
| $123.32M | ||
| 20.01% | ||
| $447.18M | ||
| 72.56% | ||
| $123.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 4.10 | ||
| 3.29 | ||
| - | ||
| 5 | ||
| 12.01 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 19.66 | ||
| 10.33 | ||
| 13.68 | ||
| 61.55 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $648.02M | ||
| $141.97M | ||
| $1.06B | ||
| $630.76M | ||
| $415.23M | ||
| $153.76M | ||
| $253.71M | ||
| $1.04M | ||
| $107.51M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $169.11M | ||
| $392.25M | ||
| $100.71M | ||
| $232.03M | ||
| $1.99M | ||
| $0.00 | ||
| -$339.79M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$24.77M | ||
| $13.80M | ||
| -$89.73M | ||
| $214.00K | ||
| -$24.99M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| JP Morgan | → | |
| B. Riley Securities | → | |
| HC Wainwright & Co. | → | |
| B of A Securities | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| JP Morgan | → | |
| Goldman Sachs | → |
Analyst sentiment
Institutional ownership
Screeners with TGTX
FAQ
- What is the ticker symbol for TG Therapeutics, Inc.?
- The ticker symbol for TG Therapeutics, Inc. is NASDAQ:TGTX
- Does TG Therapeutics, Inc. pay dividends?
- No, TG Therapeutics, Inc. does not pay dividends
- What sector is TG Therapeutics, Inc. in?
- TG Therapeutics, Inc. is in the Healthcare sector
- What industry is TG Therapeutics, Inc. in?
- TG Therapeutics, Inc. is in the Biotechnology industry
- What country is TG Therapeutics, Inc. based in?
- TG Therapeutics, Inc. is headquartered in United States
- When did TG Therapeutics, Inc. go public?
- TG Therapeutics, Inc. initial public offering (IPO) was on May 3, 2010
- Is TG Therapeutics, Inc. in the S&P 500?
- No, TG Therapeutics, Inc. is not included in the S&P 500 index
- Is TG Therapeutics, Inc. in the NASDAQ 100?
- No, TG Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is TG Therapeutics, Inc. in the Dow Jones?
- No, TG Therapeutics, Inc. is not included in the Dow Jones index
- When was TG Therapeutics, Inc. last earnings report?
- TG Therapeutics, Inc.'s most recent earnings report was on August 3, 2026
- When does TG Therapeutics, Inc. report earnings?
- The next expected earnings date for TG Therapeutics, Inc. is November 2, 2026
Data Sources & References
- TGTX Official Website www.tgtherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1001316/000143774926006133/0001437749-26-006133-index.htm
- TGTX Profile on Yahoo Finance finance.yahoo.com/quote/TGTX
- TGTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tgtx